Caas Capital Management LP Legend Biotech Corp Transaction History

Caas Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$31.02 - $48.18 $1.44 Million - $2.23 Million	-46,334 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$41.14 - $56.98 $1.91 Million - $2.64 Million	46,334 New	46,334 $2.16 Million
Q3 2020 Nov 09, 2020	SELL	$27.5 - $39.61 $2.2 Million - $3.17 Million	-80,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$36.1 - $42.56 $2.89 Million - $3.4 Million	80,000 New	80,000 $3.41 Million

225

74.3M

279K

350K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $5.49B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Caas Capital Management LP with notifications on news.